This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dallinger, S. Articles by Schmetterer, L. Search for Related Content PubMed PubMed Citation Articles by Dallinger, S. Articles by Schmetterer, L. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ACETAZOLAMIDE

(Stroke. 1998;29:997-1001.)
© 1998 American Heart Association, Inc.

Original Contributions

Effects of Acetazolamide on Choroidal Blood Flow

Susanne Dallinger, MD; Barbara Bobr, MD; Oliver Findl, MD; Hans-Georg Eichler, MD; Leopold Schmetterer, PhD

From the Departments of Clinical Pharmacology (S.D., B.B., H.-G.E., L.S.) and Ophthalmology (O.F.) and the Institute of Medical Physics (L.S.), University of Vienna (Austria).

Correspondence to Dr L. Schmetterer, Department of Clinical Pharmacology, University of Vienna, Währinger Gürtel 18–20, A-1090 Vienna, Austria. E-mail Klin-Pharmakologie{at}univie.ac.at

Background and Purpose—The acetazolamide provocation test is commonly used to study cerebrovascular vasomotor reactivity. On the basis of the effect of a carbonic anhydrase inhibitor in the central nervous system, we hypothesized that acetazolamide may also increase blood flow in the human choroid.

Methods—In a placebo-controlled, randomized, double-blind, three-way crossover design, acetazolamide (500 mg or 1000 mg IV) or placebo was administered to nine healthy subjects. The effect of acetazolamide was studied at 15-minute intervals for 90 minutes. Pulsatile choroidal blood flow was assessed with laser interferometric measurement of fundus pulsation. In addition, mean blood flow velocity and resistive index in the ophthalmic artery were measured with Doppler sonography. In a second study in six healthy subjects, we assessed the effect of acetazolamide (1000 mg IV) on intraocular pressure.

Results—Acetazolamide increased fundus pulsation amplitude in a dose-dependent manner (1000 mg: +33%; 500 mg: +20%; P<0.001, ANOVA). The effect of acetazolamide on MFV (1000 mg: +18%; 500 mg: +8%; P=0.003, ANOVA) and RI (1000 mg: -4%; 500 mg: -2%; P=0.006, ANOVA) was less pronounced but also significant. Acetazolamide did not induce any changes in systemic hemodynamic parameters but significantly decreased intraocular pressure (1000 mg: -37%; P<0.0001).

Conclusions—The present data show for the first time that intravenously administered acetazolamide increases choroidal blood flow in humans. This phenomenon therefore indicates that the acetazolamide provocation test may qualify as a tool to investigate ocular vasomotor reactivity in a variety of ocular diseases. Moreover, the increase in choroidal blood flow after carbonic anhydrase inhibition can be expected to contribute to the therapeutic efficacy of carbonic anhydrase inhibitors in glaucoma.

Key Words: acetazolamide • choroidal blood flow • ultrasonography, Doppler • vasomotor reactivity

This article has been cited by other articles:

				B Siesky, A Harris, L B Cantor, L Kagemann, Y Weitzman, L McCranor, C Marques, A Werne, and E Stefansson A comparative study of the effects of brinzolamide and dorzolamide on retinal oxygen saturation and ocular microcirculation in patients with primary open-angle glaucoma Br. J. Ophthalmol., April 1, 2008; 92(4): 500 - 504. [Abstract] [Full Text] [PDF]

				I. K. Petropoulos, J.-A. C. Pournaras, J.-L. Munoz, and C. J. Pournaras Effect of Carbogen Breathing and Acetazolamide on Optic Disc PO2 Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4139 - 4146. [Abstract] [Full Text] [PDF]

				D B Pedersen, T Eysteinsson, E Stefansson, J F Kiilgaard, M la Cour, K Bang, and P K Jensen Indomethacin lowers optic nerve oxygen tension and reduces the effect of carbonic anhydrase inhibition and carbon dioxide breathing Br. J. Ophthalmol., August 1, 2004; 88(8): 1088 - 1091. [Abstract] [Full Text] [PDF]

				B. Kiss, S. Dallinger, O. Findl, G. Rainer, H.-G. Eichler, and L. Schmetterer Acetazolamide-induced cerebral and ocular vasodilation in humans is independent of nitric oxide Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1999; 276(6): R1661 - R1667. [Abstract] [Full Text] [PDF]